UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Thrombosis and haemostasis, 2017, Vol.117 (2), p.219-230

2017

Volltextzugriff (PDF)

Predicting atrial fibrillation in primary care using machine learning

PloS one, 2019-11, Vol.14 (11), p.e0224582-e0224582

2019

Volltextzugriff (PDF)

Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database

The lancet respiratory medicine, 2020-03, Vol.8 (3), p.277-287

2020

Volltextzugriff (PDF)

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

The New England journal of medicine, 2013-02, Vol.368 (6), p.513-523

2013

Volltextzugriff (PDF)

Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer

Thrombosis and haemostasis, 2014, Vol.112 (2), p.255-263

2014

Volltextzugriff (PDF)

Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)

Cochrane database of systematic reviews, 2014-05, Vol.2018 (5), p.CD003747-CD003747

2014

Volltextzugriff (PDF)

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

The Lancet (British edition), 2008-02, Vol.371 (9610), p.387-394

2008

Volltextzugriff (PDF)

Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database

The lancet respiratory medicine, 2021-01, Vol.9 (1), p.33-42

2021

Volltextzugriff (PDF)

Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism

PloS one, 2017-11, Vol.12 (11), p.e0187648-e0187648

2017

Volltextzugriff (PDF)

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality

Thrombosis and haemostasis, 2007-10, Vol.98 (4), p.756-764

2007

Volltextzugriff (PDF)

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Thrombosis journal, 2013-09, Vol.11 (1), p.21-21

2013

Volltextzugriff (PDF)

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

PloS one, 2022-09, Vol.17 (9), p.e0274969-e0274969

2022

Volltextzugriff (PDF)

Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013

Heart (British Cardiac Society), 2015-11, Vol.101 (21), p.1748-1754

2015

Volltextzugriff (PDF)

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

Circulation (New York, N.Y.), 2004-08, Vol.110 (7), p.874-879

2004

Volltextzugriff (PDF)

Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry

Journal of the American Heart Association, 2022-10, Vol.11 (20), p.e027514-e027514

2022

Volltextzugriff (PDF)

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials

The Lancet. Haematology, 2014-10, Vol.1 (1), p.e37-e46

2014

Volltextzugriff (PDF)

Derivation and validation of a composite scoring system (SAVED 2 ) for prediction of unfavorable modified Rankin scale score following intracerebral hemorrhage

Frontiers in neurology, 2023-02, Vol.14, p.1112723-1112723

2023

Volltextzugriff (PDF)

The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study

The American heart journal, 2014-03, Vol.167 (3), p.335-341

2014

Volltextzugriff (PDF)

Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study

Thrombosis and haemostasis, 2017-01, Vol.117 (1), p.57-65

2017

Volltextzugriff (PDF)

Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolism

American journal of hematology, 2007-09, Vol.82 (9), p.777-782

2007

Volltextzugriff (PDF)

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

Journal of the American Heart Association, 2021-03, Vol.10 (5), p.e019459-e019459

2021

Volltextzugriff (PDF)

Thromboembolic Prevention in Frail Elderly Patients With Atrial Fibrillation: A Practical Algorithm

Journal of the American Medical Directors Association, 2015-05, Vol.16 (5), p.358-364

2015

Volltextzugriff (PDF)

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients

Thrombosis and haemostasis, 2005-10, Vol.94 (4), p.750-759

2005

Volltextzugriff (PDF)

Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding

Journal of the American College of Emergency Physicians Open, 2022-04, Vol.3 (2), p.e12655-n/a

2022

Volltextzugriff (PDF)

Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)

Cochrane database of systematic reviews, 2009-07 (3), p.CD003747

2009

Volltextzugriff (PDF)

1 – 25 von 3.945

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.378)
Mit Volltextzugriff
(3.214)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.209)
Life Sciences & Biomedicine
(1.757)
Humans
(1.363)
Male
(781)
Female
(772)
Middle Aged
(463)
Adult
(434)
Aged
(402)
Biological And Medical Sciences
(308)
Cardiovascular System & Cardiology
(279)
Medical Sciences
(267)
Animals
(266)
Physical Sciences
(258)
Technology
(217)
Surgery
(205)
Neurosciences & Neurology
(195)
Risk Factors
(195)
Science & Technology - Other Topics
(186)
Patients
(184)
Treatment Outcome
(182)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.697)
MEDLINE
(1.667)
IngentaConnect
(1.619)
Journals@Ovid Ovid Full Text
(1.388)
NUS Single-Journal Subscriptions
(976)
Elsevier ScienceDirect Journals Complete
(758)
IngentaConnect Journals
(599)
Wiley Online Library
(443)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(424)
SpringerLink
(282)
Wiley Online Library Full Collection 2018
(267)
JSTOR
(262)
Ebook Central Perpetual and DDA
(227)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(193)
eBooks on EBSCOhost
(165)
Springer Nature - Connect here FIRST to enable access
(145)
Oxford journals
(141)
Taylor & Francis
(126)
Taylor & Francis:Master (3349 titles)
(123)
SAGE Journals
(122)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(77)
Thrombosis And Haemostasis
(54)
Circulation
(52)
Physics Letters. B
(51)
Journal Of Clinical Oncology
(47)
Basic Life Sciences
(46)
Journal Of The American College Of Cardiology
(46)
Plasmids In Bacteria
(45)
The New England Journal Of Medicine
(45)
Plos One
(44)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Predicting atrial fibrillation in primary care using machine learning

Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer

Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database

Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials

Derivation and validation of a composite scoring system (SAVED 2 ) for prediction of unfavorable modified Rankin scale score following intracerebral hemorrhage

The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study

Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study

Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolism

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

Thromboembolic Prevention in Frail Elderly Patients With Atrial Fibrillation: A Practical Algorithm

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients

Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding

Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)

Suchergebnisse filtern